4CPS-240 Development of a 25% benzyl benzoate lotion for a case of resistant Norwegian scabies
4CPS-240 Development of a 25% benzyl benzoate lotion for a case of resistant Norwegian scabies
About this item
Full title
Author / Creator
Publisher
London: British Medical Journal Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
London: British Medical Journal Publishing Group
Subjects
More information
Scope and Contents
Contents
Background and importanceNorwegian scabies is a severe type of scabies affecting immunocompromised patients caused by Sarcoptes scabiei var. hominis, a highly contagious variant unresponsive to the first-line scabies drugs, permethrin and ivermectine.Aim and objectivesThe aim of this study was to formulate a 25% benzyl benzoate lotion for the treat...
Alternative Titles
Full title
4CPS-240 Development of a 25% benzyl benzoate lotion for a case of resistant Norwegian scabies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2672347513
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2672347513
Other Identifiers
ISSN
2047-9956
E-ISSN
2047-9964
DOI
10.1136/ejhpharm-2022-eahp.226
